Companies › AZN
ASTRAZENECA PLC (AZN)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0000901832 · EDGAR filings · Updated 2026-07-27
ASTRAZENECA PLC (AZN) has 1,312 institutional managers reporting positions valued at $149.9B per the latest 13F reporting period.
Filings this week (4)
- 2026-07-27 — Foreign issuer report (6-K) filed
- 2026-07-27 — Foreign issuer report (6-K) filed
- 2026-07-27 — Foreign issuer report (6-K) filed
- 2026-07-23 — Foreign issuer report (6-K) filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-14 — Foreign issuer report (6-K) filed
- 2026-07-09 — Foreign issuer report (6-K) filed
- 2026-07-08 — Insider transaction reported (Form 4)
- 2026-07-01 — Foreign issuer report (6-K) filed
- 2026-07-01 — Foreign issuer report (6-K) filed
- 2026-06-29 — 11-K filed
- 2026-06-29 — Foreign issuer report (6-K) filed
- 2026-06-29 — Foreign issuer report (6-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, ASTRAZENECA PLC has 1,312 institutional holders.
| # | Institution | Reported value | % of tracked total |
|---|---|---|---|
| 1 | INVESTOR AB | $10.2B | 6.8% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | $8.81B | 5.9% |
| 3 | Capital International Investors | $6.72B | 4.5% |
| 4 | FMR LLC | $5.80B | 3.9% |
| 5 | Capital World Investors | $5.52B | 3.7% |
| 6 | Legal & General Group Plc | $5.01B | 3.3% |
| 7 | WELLINGTON MANAGEMENT GROUP LLP | $4.63B | 3.1% |
| 8 | PRICE T ROWE ASSOCIATES INC /MD/ | $3.84B | 2.6% |
| 9 | BANK OF AMERICA CORP /DE/ | $3.76B | 2.5% |
| 10 | VANGUARD ASSET MANAGEMENT, Ltd | $3.62B | 2.4% |
Full holder history and quarter-over-quarter changes are available inside the app.
Insider activity
Insiders reported 0 transactions (0 buys, 0 sells) across 1 reporting insiders, with a net reported value of $0.
Debt maturity schedule
Principal coming due by year for ASTRAZENECA PLC, from the company's own SEC prospectus filings (424B) tracked by Sightfile.
| Year | Bond series maturing | Known principal due |
|---|---|---|
| 2027 | 2 | — |
| 2029 | 2 | — |
| 2030 | 2 | — |
| 2032 | 1 | — |
| 2037 | 2 | — |
| 2042 | 1 | — |
| 2045 | 2 | — |
| 2048 | 2 | — |
| 2050 | 2 | — |
| 2051 | 1 | — |
Coupons, seniority and prospectus links for each series are available inside the app.
Related companies
ABBVIE INC (ABBV) · MERCK & CO. INC. (MRK) · AMGEN INC (AMGN) · GILEAD SCIENCES INC (GILD) · ABBOTT LABS (ABT) · INTUITIVE SURGICAL INC (ISRG)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-27.